INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 439m ago
HOUSE PTR39m ago
SEC 13F39m ago
ROBINHOOD CHAIN39m ago
Public company

Moleculin Biotech, Inc.

MBRXCIK 0001659617

EDGAR filingsOpen in network
Price$8.70
1 year-27.0%
Disclosed transactions9
Buys / sells0 / 0
Max Insider Score9
Connections with evidence4

MBRX · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
PH
Picker Donald HChief Science Officer
MBRXMoleculin Biotech, Inc.
Option exercise
M—
17 sh
Nov 4, 2026Nov 6, 2026

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 6, 2026
  • ← Insider ofevidence
    Picker Donald HChief Science Officer · Nov 6, 2026
  • ← Insider ofevidence
    Foster Jonathan P.Chief Financial Officer · Nov 6, 2026
  • ← Insider ofevidence
    Klemp Walter VDirector, CEO and President · Nov 6, 2026
traded Nov 4, 2026
+2d
SEC FORM 4

Evidence

9
PH
Picker Donald HChief Science Officer
MBRXMoleculin Biotech, Inc.
Tax withholding
F$33.84
4 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

9
PH
Picker Donald HChief Science Officer
MBRXMoleculin Biotech, Inc.
Option exercise
M—
18 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

9
FP
Foster Jonathan P.Chief Financial Officer
MBRXMoleculin Biotech, Inc.
Option exercise
M—
41 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

9
FP
Foster Jonathan P.Chief Financial Officer
MBRXMoleculin Biotech, Inc.
Tax withholding
F$84.6
10 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

9
FP
Foster Jonathan P.Chief Financial Officer
MBRXMoleculin Biotech, Inc.
Option exercise
M—
41 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

9
KV
Klemp Walter VDirector, CEO and President
MBRXMoleculin Biotech, Inc.
Option exercise
M—
57 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

9
KV
Klemp Walter VDirector, CEO and President
MBRXMoleculin Biotech, Inc.
Tax withholding
F$118
14 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

9
KV
Klemp Walter VDirector, CEO and President
MBRXMoleculin Biotech, Inc.
Option exercise
M—
57 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence